developing world HIV/AIDS

Generic hepatitis C drugs continue to produce high cure rates

Treatment with generic versions of direct-acting antiviral drugs continues to produce similar cure rates to those reported in clinical trials, Dr James Freeman reported last week at the International Liver Congress in Amsterdam. Dr James Freeman, an Australian general...

read more

AbbVie combination cures 95% of genotype 3 hepatitis C

AbbVie’s pangenotypic direct-acting antiviral combination of two drugs cured 95% of people with early-stage genotype 3 hepatitis C virus (HCV), the hardest genotype to treat, according to results of the ENDURANCE-3 trial presented at the International Liver...

read more

AbbVie combination cures 97% of genotype 3 hepatitis C

AbbVie’s pangenotypic direct-acting antiviral combination of two drugs cured 97% of people with early-stage genotype 3 hepatitis C virus (HCV), the hardest genotype to treat, according to results of the ENDURANCE-3 trial presented at the International Liver...

read more

Curing hepatitis C reduces cardiovascular risk

Curing hepatitis C reduces the risk of cardiovascular events in people with compensated cirrhosis, a large French study presented this week at the International Liver Congress in Amsterdam shows. Presenting the findings, Patrice Cacoub of Hôpital Pitié-Salpêtrière,...

read more